UK markets closed

AMGN Oct 2024 270.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
23.330.00 (0.00%)
As of 12:25PM EDT. Market open.
Full screen
Previous close23.33
Open23.33
Bid25.35
Ask27.50
Strike270.00
Expiry date2024-10-18
Day's range23.33 - 23.33
Contract rangeN/A
Volume2
Open interest36
  • Reuters

    UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%

    Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish ... although not anything significant for the Street given that it is still early in the year," David Song, portfolio manager of the Tema Obesity & Cardiometabolic ETF said in an email.

  • Investor's Business Daily

    Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up

    Amgen stock popped late Thursday despite its profit beat as investors watch its potential rivals to Lilly and Novo drugs.

  • Reuters

    Amgen first-quarter profit dips 1%, revenue rises 22%

    (Reuters) -Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish ... although not anything significant for the Street given that it is still early in the year," David Song, portfolio manager of the Tema Obesity & Cardiometabolic ETF said in an email.